MilliporeSigma
HomeServicesProduct ServicesEmprove® ProgramEmprove® Dossiers for Cell Culture Media in Upstream Processes

Emprove® Dossiers for Cell Culture Media in Upstream Processes

Illustration of scientist focused on quality of final drug product, supported by Emprove® CCM portfolio

Cell culture media (CCM) drive the productivity of upstream processes and help ensure critical quality attributes of the final drug product. Because of this critical role in manufacturing, along with increased regulatory focus on raw materials, it is recommended that media be included in drug product risk assessments.1,2

To ease the burden of collecting the extensive information needed for a thorough assessment, Cellvento® CHO cell culture media are included in our Emprove® Program.  

Subscribe to Emprove® Suite

Dossiers that support upstream productivity, risk assessment, and product quality

As part of the Emprove® Program, cell culture media in our Emprove® CCM portfolio include comprehensive dossiers that facilitate your process optimization, risk assessment, and quality efforts. 

Target Emprove® Dossier Availability for Cellvento® Media


The new Emprove<sup>®</sup> Suite

THE NEW EMPROVE® SUITE: SPEED THROUGH COMPLEXITY WITH CONFIDENCE

Compliance with current Good Manufacturing Practices is a continuum. Changes are inevitable. Audits and periodic reviews are necessary.

Take a seat: The Emprove® Suite is here to improve your risk assessment journey. This  Information-as-a-Service digital platform is your co-pilot to support your need for convenient access to reliable information – anywhere, anytime. A subscription helps you stay current:  You can  not only easily find, view and download Emprove® Dossiers, but also to “opt-in” to notification updates to be informed of changes to documents. You can also generate Emprove® Dossier download metrics and reports, and so much more.

Ultimately, a subscription to the Emprove® Suite empowers you to:

  • take advantage of everything the Emprove® Program has to offer
  • collaborate and share information globally
  • speed your way through the complexity of compliance with confidence

Related Product Resources




To subscribe today, simply complete and submit the reply form below after reading our Emprove® terms and conditions.

References

1.
Sept. 2019. Raw Material Risk Assessments – A Holistic Approach to Raw Material Risk Assessments through Industrial Collaboration. BioPhorum.
2.
Dec. 2018. Management and Control of Raw Materials Used in the Manufacture of Biological Medicinal Products and ATMPs. European Biopharmaceutical Enterprises.
Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?